Risk factors for preeclampsia in women from Colombia: A case-control study

PLoS ONE

Volumn 7, Issue 7, 2012, Pages

  Reyes, Laura M ^a   García, Ronald G ^a   Ruiz, Silvia L ^a   Camacho, Paul A ^a   Ospina, Maria B ^b   Aroca, Gustavo ^c   Accini, Jose L ^d   López Jaramillo, Patricio ^e,f  

^a FUNDACIÓN CARDIOVASCULAR DE COLOMBIA   (Colombia)

^b UNIVERSITY OF ALBERTA   (Canada)

^c Clínica de la Costa   (Colombia)

^d Hospital Universitario de Barranquilla   (Colombia)

^e UNIVERSIDAD DE SANTANDER   (Colombia)

^f Research Institute of the Fundacion Oftalmologica de Santander FOSCAL   (Colombia)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ARTICLE; BODY MASS; CASE CONTROL STUDY; COLOMBIA; DIASTOLIC BLOOD PRESSURE; FEMALE; GESTATIONAL AGE; GLUCOSE BLOOD LEVEL; HEART RATE; HUMAN; LEUKOCYTE COUNT; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; METABOLIC SYNDROME X; PREECLAMPSIA; PRIMIGRAVIDA; RISK ASSESSMENT; RISK FACTOR; SYSTOLIC BLOOD PRESSURE; THROMBOCYTE COUNT; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; CASE-CONTROL STUDIES; COLOMBIA; DEMOGRAPHY; FEMALE; HUMANS; MULTIVARIATE ANALYSIS; PRE-ECLAMPSIA; PREGNANCY; RISK FACTORS;

EID: 84864254168     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0041622     Document Type: Article

References (44)

1. Walker JJ, (2000) Pre-eclampsia. Lancet 356(9237): 1260-1265.
2. Christiansen LR, Collins KA, (2006) Pregnancy-associated deaths: A 15-year retrospective study and overall review of maternal pathophysiology. Am J Forensic Med Pathol 27(1): 11-19.
3. Osungbade KO, Ige OK, (2011) Public health perspectives of preeclampsia in developing countries: Implication for health system strengthening. J Pregnancy 2011: 481095.
4. Khan KS, Wojdyla D, Say L, Gulmezoglu AM, Van Look PF, (2006) WHO analysis of causes of maternal death: A systematic review. Lancet 367(9516): 1066-1074.
5. Duckitt K, Harrington D, (2005) Risk factors for pre-eclampsia at antenatal booking: Systematic review of controlled studies. BMJ 330(7491): 565.
6. Kaaja R, (2008) Predictors and risk factors of pre-eclampsia. Minerva Ginecol 60(5): 421-429.
7. Lopez-Jaramillo P, Pradilla LP, Castillo VR, Lahera V, (2007) Socioeconomic pathology as a cause of regional differences in the prevalence of metabolic syndrome and pregnancy-induced hypertension. Rev Esp Cardiol 60(2): 168-178.
8. Lopez-Jaramillo P, Garcia RG, Lopez M, (2005) Preventing pregnancy-induced hypertension: Are there regional differences for this global problem? J Hypertens 23(6): 1121-1129.
9. López-Jaramillo P, Herrera E, Garcia RG, Camacho PA, Castillo VR, (2008) Inter-relationships between body mass index, C-reactive protein and blood pressure in a hispanic pediatric population. Am J Hypertens 21: 527-32.
10. Chavarro JE, Rich-Edwards JW, Rosner BA, Willett WC, (2009) A prospective study of dietary carbohydrate quantity and quality in relation to risk of ovulatory infertility. Eur J Clin Nutr 63: 78-86.
11. Saldana TM, Siega-Riz AM, Adair LS, (2004) Effect of macronutrient intake on the development of glucose intolerance during pregnancy. Am J Clin Nutr 79(3): 479-486.
12. Vambergue A, Nuttens MC, Goeusse P, Biausque S, Lepeut M, et al. (2002) Pregnancy induced hypertension in women with gestational carbohydrate intolerance: The diagest study. Eur J Obstet Gynecol Reprod Biol 102(1): 31-35.
13. Lopez-Jaramillo P, (2008) Defining the research priorities to fight the burden of cardiovascular diseases in latin america. J Hypertens 26(9): 1886-1889.
14. Reyes L, Garcia R, Ruiz S, Dehghan M, Lopez-Jaramillo P, (2012) Nutritional status among women with pre-eclampsia and healthy pregnant and non-pregnant women in a latin american country. J Obstet Gynaecol Res 38(3): 498-504.
15. Reyes LM, García RG, Ruíz SL, Broadhurst D, Aroca G, et al. (2012) Angiogenic imbalance and plasma lipid alterations in women with preeclampsia from a developing country. Growth Factors [Epub] doi:10.3109/08977194.2012.674035.
16. Report of the National High Blood Pressure Education Program (2000) Working group report on high blood pressure in pregnancy. Am J Obstet Gynecol 183: S1-S22.
17. Sibai BM, (2003) Diagnosis and management of gestational hypertension and preeclampsia. Obstet Gynecol 102(1): 181-192.
18. Dane B, Dane C, Kiray M, Koldas M, Cetin A, (2009) A new metabolic scoring system for analyzing the risk of hypertensive disorders of pregnancy. Arch Gynecol Obstet 280(6): 921-924.
19. Druzin ML, Charles B, Johnson AL, (2008) Editorial summary of symposium on hypertensive disorders of pregnancy. Curr Opin Obstet Gynecol 20(2): 91.
20. Herrera JA, Chaudhuri G, López-Jaramillo P, (2001) Is infection a major risk for preeclampsia? Med Hypotheses 57: 393-7.
21. Sierra-Laguado J, García RG, Celedón J, Arenas-Mantilla M, Pradilla LP, et al. (2007) Determination of insulin resistance using the homeostatic model assessment (HOMA) and its relation with the risk of developing pregnancy-induced hypertension. Am J Hypertens 20: 437-42.
22. Garcia RG, Celedon J, Sierra-Laguado J, Alarcon MA, Luengas C, et al. (2007) Raised C-reactive protein and impaired flow-mediated vasodilation precede the development of preeclampsia. Am J Hypertens 20(1): 98-103.
23. Rueda-Clausen CF, Silva FA, Lopez-Jaramillo P, (2008) Epidemic of overweight and obesity in latin america and the caribbean. Int J Cardiol 125(1): 111-112.
24. Belfort R, Mandarino L, Kashyap S, Wirfel K, Pratipanawatr T, et al. (2005) Dose-response effect of elevated plasma free fatty acid on insulin signaling. Diabetes 54(6): 1640-1648.
25. Wellen KE, Hotamisligil GS, (2003) Obesity-induced inflammatory changes in adipose tissue. J Clin Invest 112(12): 1785-1788.
26. Bhagat K, Vallance P, (1997) Inflammatory cytokines impair endothelium-dependent dilatation in human veins in vivo. Circulation 96(9): 3042-3047.
27. Bautista LE, Lopez-Jaramillo P, Vera LM, Casas JP, Otero AP, et al. (2001) Is C-reactive protein an independent risk factor for essential hypertension? J Hypertens 19(5): 857-861.
28. Danesh J, Wheeler JG, Hirschfield GM, Eda S, Eiriksdottir G, et al. (2004) C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 350(14): 1387-1397.
29. Rost NS, Wolf PA, Kase CS, Kelly-Hayes M, Silbershatz H, et al. (2001) Plasma concentration of C-reactive protein and risk of ischemic stroke and transient ischemic attack: The framingham study. Stroke 32(11): 2575-2579.
30. Driul L, Cacciaguerra G, Citossi A, Martina MD, Peressini L, et al. (2008) Prepregnancy body mass index and adverse pregnancy outcomes. Arch Gynecol Obstet 278(1): 23-26.
31. Crane JM, White J, Murphy P, Burrage L, Hutchens D, (2009) The effect of gestational weight gain by body mass index on maternal and neonatal outcomes. J Obstet Gynaecol can 31(1): 28-35.
32. Nordin NM, Wei JW, Naing NN, Symonds EM, (2006) Comparison of maternal-fetal outcomes in gestational diabetes and lesser degrees of glucose intolerance. J Obstet Gynaecol Res 32(1): 107-114.
33. Sermer M, Naylor CD, Gare DJ, Kenshole AB, Ritchie JW, et al. (1995) Impact of increasing carbohydrate intolerance on maternal-fetal outcomes in 3637 women without gestational diabetes. the toronto tri-hospital gestational diabetes project. Am J Obstet Gynecol 173(1): 146-156.
34. Joffe GM, Esterlitz JR, Levine RJ, Clemens JD, Ewell MG, et al. (1998) The relationship between abnormal glucose tolerance and hypertensive disorders of pregnancy in healthy nulliparous women. Calcium for preeclampsia prevention (CPEP) study group. Am J Obstet Gynecol 179(4): 1032-1037.
35. Ray JG, Diamond P, Singh G, Bell CM, (2006) Brief overview of maternal triglycerides as a risk factor for pre-eclampsia. BJOG 113(4): 379-386.
36. Cekmen MB, Erbagci AB, Balat A, Duman C, Maral H, et al. (2003) Plasma lipid and lipoprotein concentrations in pregnancy induced hypertension. Clin Biochem 36(7): 575-578.
37. Martin U, Davies C, Hayavi S, Hartland A, Dunne F, (1999) Is normal pregnancy atherogenic? Clin Sci (Lond) 96(4): 421-425.
38. Kuhl C, (1991) Insulin secretion and insulin resistance in pregnancy and GDM. Implications for diagnosis and management. Diabetes 40: 18-24.
39. Ness RB, Markovic N, Bass D, Harger G, Roberts JM, (2003) Family history of hypertension, heart disease, and stroke among women who develop hypertension in pregnancy. Obstet Gynecol 102(6): 1366-1371.
40. Qiu C, Williams MA, Leisenring WM, Sorensen TK, Frederick IO, et al. (2003) Family history of hypertension and type 2 diabetes in relation to preeclampsia risk. Hypertension 41(3): 408-413.
41. López-Jaramillo P, Garcia R, Reyes LM, Ruiz S, (2009) Appropriate prenatal care system: The best way to prevent preeclampsia. Colomb Med 40: 226-30.
42. Bellamy L, Casas JP, Hingorani AD, Williams DJ, (2007) Pre-eclampsia and risk of cardiovascular disease and cancer in later life: Systematic review and meta-analysis. BMJ 335(7627): 974.
43. Lopez-Jaramillo P, (2009) Cardiometabolic disease in latin america: The role of fetal programming in response to maternal malnutrition. Rev Esp Cardiol 62(6): 670-676.
44. Miettinen OS, (1985) Theoretical epidemiology: Principles of occurrence research in medicine. New York (NY): Wiley.